Company intelligence / Profile preview

myNEO Therapeutics

Ownership: Private
Employees: ~20
Development stage: Preclinical

Overview

myNEO Therapeutics has developed state-of-the-art AI algorithms for antigen prediction and has discovered novel dark genome-derived antigens ("camyotopes"). Its lead mRNA vaccine candidate for colorectal cancer (CAMYO-01) is moving toward clinical development. The company’s approach aims to unlock immunotherapy options for patients who currently do not respond to existing treatments by targeting previously untapped genomic regions. Preclinical validation supports the potential of camyotopes as game-changing targets in oncology[3][6].

Therapeutic areas: Oncology
Modalities: mRNA-based cancer vaccinesimmunotherapies
Industry: Biotech

Drug pipeline

10 assets

CAMYO-01

Preclinical

9 more assets in the full pipeline.

Partnerships

Strategic collaborations with academic institutions and biopharma companies for co-development of products and services via the myNEO Intelligence platform; specific partners not named in public sources[1][2].

Beyond the preview

Go deeper on myNEO Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on myNEO Therapeutics.